BRCA1 mutations in Brazilian patients

被引:14
作者
Lourenço, JJ
Vargas, FR
Bines, J
Santo, EM
Lasmar, CAP
Costa, UH
Teixeira, EMB
Maia, MCM
Coura, F
Silva, CHD
Moreira, MAM
机构
[1] Inst Nacl Canc, Div Genet, BR-20231050 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil
[4] HCI, Inst Nacl Canc, Rio De Janeiro, Brazil
[5] HCII, Inst Nacl Canc, Rio De Janeiro, Brazil
[6] HCIII, Inst Nacl Canc, Rio De Janeiro, Brazil
关键词
BRCA1; breast cancer; ovarian cancer;
D O I
10.1590/S1415-47572004000400006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 mutations are known to be responsible for the majority of hereditary breast and ovarian cancers in women with early onset and a family history of the disease. In this paper we present a mutational survey conducted in 47 Brazilian patients with breast/ovarian cancer, selected based on age at diagnosis, family history, tumor laterality, and presence of breast cancer in male patients. All 22 coding exons and intron-exon junctions were sequenced. Constitutional mutations were found in seven families, consisting of one insertion (insC5382) in exon 20 (four patients), one four base-pair deletion (3450-3453delCAAG) in exon 11 resulting in a premature stop codon (one patient), one transition (IVS17 + 2T > C) in intron 17 affecting a mRNA splicing site (one patient), and a C > T transition resulting in a stop-codon (Q1135X) in exon 11 (one patient). The identification of these mutations which are associated to hereditary breast and ovarian cancers will contribute to the characterization of the mutational spectrum of BRCA1 and to the improvement of genetic counseling for familial breast/ovarian cancer patients in Brazil.
引用
收藏
页码:500 / 504
页数:5
相关论文
共 40 条
[1]  
Abeliovich D, 1997, AM J HUM GENET, V60, P505
[2]   The ancestry of Brazilian mtDNA lineages [J].
Alves-Silva, J ;
Santos, MD ;
Guimaraes, PEM ;
Ferreira, ACS ;
Bandelt, HJ ;
Pena, SDJ ;
Prado, VF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (02) :444-461
[3]  
Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365
[4]   Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients:: Identification of a novel deletion consistent with BRCA1:ψVBRCA1 recombination [J].
Brown, MA ;
Lo, LJ ;
Catteau, A ;
Xu, CF ;
Lindeman, GJ ;
Hodgson, S ;
Solomon, E .
HUMAN MUTATION, 2002, 19 (04) :435-442
[5]   The phylogeography of Brazilian Y-chromosome lineages [J].
Carvalho-Silva, DR ;
Santos, FR ;
Rocha, J ;
Pena, SDJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (01) :281-286
[6]  
COVELLO CM, 1998, BREAST CANC RES TREA, V50, P297
[7]   Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer [J].
de los Rios, P ;
Jack, E ;
Kuperstein, G ;
Lynch, H ;
Lubinski, J ;
Narod, SA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (02) :546-546
[8]  
DELGADO LB, 2003, BRCA1 BRCA2 MUTATION
[9]  
Dong J, 1998, HUM GENET, V103, P154
[10]   Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites [J].
Durocher, F ;
Tonin, P ;
ShattuckEidens, D ;
Skolnick, M ;
Narod, SA ;
Simard, J .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (10) :814-819